SANGAMO THERAPEUTICS, INC - COM (SGMO)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
99.8 M
Holdings value Q1 2024
$66.8 M
Value change Q1 2024
+$9.87 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
121
Number of buys Q1 2024
46
Number of sells Q1 2024
-64
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
800677106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 99.8 M $66.8 M +$9.87 M $0.67 123
2023 Q4 85.5 M $46.4 M -$9.3 M $0.54 125
2023 Q3 102 M $61.1 M -$4.21 M $0.60 128
2023 Q2 105 M $136 M -$10.6 M $1.30 146
2023 Q1 110 M $193 M +$11.8 M $1.76 173
2022 Q4 103 M $324 M +$18.1 M $3.14 173
2022 Q3 91 M $446 M +$40.1 M $4.90 180
2022 Q2 88.9 M $368 M +$45.6 M $4.14 170
2022 Q1 77.7 M $452 M +$17.4 M $5.81 176
2021 Q4 75.5 M $567 M +$12.7 M $7.50 177
2021 Q3 75.2 M $679 M -$11.4 M $9.01 187
2021 Q2 76.2 M $911 M -$39.8 M $11.97 192
2021 Q1 79 M $990 M +$8.42 M $12.53 192
2020 Q4 78 M $1.22 B -$2.07 M $15.61 213
2020 Q3 81.5 M $771 M +$42.9 M $9.45 196
2020 Q2 77 M $690 M +$38.5 M $8.96 195
2020 Q1 73.9 M $471 M -$44.1 M $6.37 167
2019 Q4 78 M $653 M -$35.5 M $8.37 184
2019 Q3 82.1 M $743 M +$18.2 M $9.05 176
2019 Q2 79.8 M $860 M +$188 M $10.77 177
2019 Q1 62.1 M $593 M +$8.48 M $9.54 173
2018 Q4 63.9 M $733 M -$24.4 M $11.48 183
2018 Q3 63.3 M $1.07 B +$5.36 M $16.95 211
2018 Q2 64.6 M $918 M +$102 M $14.20 205
2018 Q1 57.2 M $1.09 B +$32 M $19.00 204
2017 Q4 55.5 M $911 M +$36.7 M $16.40 166
2017 Q3 54.7 M $820 M +$37.4 M $15.00 149
2017 Q2 53 M $467 M +$101 M $8.80 145
2017 Q1 41.8 M $218 M +$36.4 M $5.20 113
2016 Q4 41 M $125 M -$11.9 M $3.05 118
2016 Q3 43.6 M $202 M -$12.3 M $4.63 120
2016 Q2 46.2 M $267 M -$15.6 M $5.79 135
2016 Q1 48.7 M $292 M -$3.98 M $6.05 140
2015 Q4 48.7 M $445 M -$33.2 M $9.13 138
2015 Q3 51.2 M $289 M -$28.4 M $5.64 141
2015 Q2 49.6 M $550 M -$34.3 M $11.09 154
2015 Q1 51 M $799 M +$55.4 M $15.68 165
2014 Q4 46.4 M $705 M -$11 M $15.21 157
2014 Q3 48.1 M $518 M +$6.23 M $10.79 156
2014 Q2 45.6 M $696 M +$28.9 M $15.27 151
2014 Q1 47.7 M $863 M +$75.3 M $18.08 146